Drug development for neurodegenerative diseases.
既承認薬を有効活用したiPS創薬により見出された難治性疾患の根本治療薬 現在、難治性疾患であるアルツハイマー病は、対症療法薬しかなく、大きな社会問題になっています。特に家族性アルツハイマー病の方は、...
契約に関わる技術内容について 本特許は、京都大学が出願した特許であり、京都大学iPS細胞研究所で開発された技術をもとに、薬剤スクリーニングを実施し発見された化合物に関わるもので、アルツハイマー病に対...
CarbGeM is driving innovation in the life sciences through cutting-edge technologies, including regulatory-approved Software as a Medical Device (SaMD). The company empowers diagnostic support, research efficiency, and the standardization and automation of quality control. While addressing social challenges such as a shortage of skilled professionals and regional healthcare disparities, CarbGeM supports medical and industrial sectors by providing accurate and rapid results. Leveraging AI and digital platforms, the company fosters collaboration among healthcare professionals and researchers worldwide. CarbGeM is actively engaged in co-creating the future of medicine and science through open innovation with leading institutions across industry, academia, and government. The company has received numerous honors, including the Tokyo Social Innovation Tech Award 2024.
Tellme's original business was operating hair salons. Over years of observing changes in their clientele, and as a service for customers who could no longer visit the salon due to illness or aging, the company developed a technology to assess the risk of glycation (a measure of aging) through hair analysis. This technology is currently being promoted as a diabetes screening technology. After being featured at the World Expo, it gained significant attention from overseas countries and institutions for its ability to assess risk without the need for blood sampling. In Japan, the technology is also seen as contributing to behavioral change among the segment of the population indifferent to their own health (kenko mukanshinsō) within local municipalities. Tellme is now pursuing the commercialization of this service as a means of optimizing social security costs.
A Tokushima University-spinoff startup developing digital dental crown technology that treats teeth without grinding healthy enamel. By designing crowns that only replace necessary parts, it provides solutions to dental clinics, with adoption at 250 clinics nationwide, contributing to reduced patient costs and improved treatment precision.
A startup developing proprietary technology that utilizes fish-derived gut bacteria to enhance aquaculture fish growth and strengthen immunity. Centered on aquaculture support through bacterial cocktails, it also tackles land-based aquaculture and branded fish production.
